<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To evaluate the relationship of <z:hpo ids='HP_0005202'>Helicobacter pylori infection</z:hpo> to reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo> (RE), <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) and gastric <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (IM) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: RE, BE and gastric IM were determined by upper endoscopy </plain></SENT>
<SENT sid="2" pm="."><plain>Patients were divided into 2 groups; those with squamocolumnar junction (SCJ) beyond gastroesophageal junction (GEJ) &gt; =3 cm (group A), and those with SCJ beyond GEJ &lt;3 cm (group B) </plain></SENT>
<SENT sid="3" pm="."><plain>Biopsy specimens were obtained endoscopically from just below the SCJ, gastric antrum along the greater and lesser curvature </plain></SENT>
<SENT sid="4" pm="."><plain>Pathological changes and <z:e sem="disease" ids="C0850666" disease_type="Disease or Syndrome" abbrv="">H pylori infection</z:e> were determined by HE staining, Alcian blue staining and Giemsa staining </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The prevalence of <z:e sem="disease" ids="C0850666" disease_type="Disease or Syndrome" abbrv="">H pylori infection</z:e> was 46.93% </plain></SENT>
<SENT sid="6" pm="."><plain>There was no difference in the prevalence between males and females </plain></SENT>
<SENT sid="7" pm="."><plain>The prevalence of <z:e sem="disease" ids="C0850666" disease_type="Disease or Syndrome" abbrv="">H pylori infection</z:e> decreased stepwise significantly from RE grade I to III </plain></SENT>
<SENT sid="8" pm="."><plain>There was no difference in the prevalence between the two groups, and between long-segment and short-segment BE </plain></SENT>
<SENT sid="9" pm="."><plain>In distal stomach, prevalence of <z:e sem="disease" ids="C0850666" disease_type="Disease or Syndrome" abbrv="">H pylori infection</z:e> was significantly higher in patients with IM than those without IM </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: There is a protective role of <z:e sem="disease" ids="C0850666" disease_type="Disease or Syndrome" abbrv="">H pylori infection</z:e> to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>There may be no relationship between <z:e sem="disease" ids="C0850666" disease_type="Disease or Syndrome" abbrv="">H pylori infection</z:e> of stomach and BE </plain></SENT>
<SENT sid="12" pm="."><plain><z:e sem="disease" ids="C0850666" disease_type="Disease or Syndrome" abbrv="">H pylori infection</z:e> is associated with the development of IM in the distal stomach </plain></SENT>
</text></document>